Mental Health
ASCO has released new guidelines to help doctors offer the most effective treatments for anxiety and depression after a cancer diagnosis.
More than half of people who have been diagnosed with cancer feel lonely, most likely as a result of social distancing and isolation during the COVID-19 pandemic.
Mindfulness meditation and survivorship education classes eased symptoms of depression in younger women treated for breast cancer.
Community-based support organizations are essential in helping Black women in Memphis who have been diagnosed with breast cancer overcome barriers to care.
A study suggests offering mindfulness-based cognitive behavioral therapy via the Internet offers the same benefits as face-to-face sessions.
Research suggests that the CALM (Managing Cancer And Living Meaningfully) therapy program can help ease depression in people living with advanced-stage cancer.
A specific type of counseling therapy, called blended cognitive behavior therapy, can help ease the fear of a cancer recurrence in survivors.
Research suggests that nearly half of the partners of younger women diagnosed with breast cancer experienced anxiety, sometimes years after the diagnosis.
A small study found that the Mindfulness-Based Stress Reduction for Breast Cancer program improved the physical and emotional health of women who had been treated for early-stage disease.
A study found that a web-based tool can help women feel less stressed and anxious after breast cancer treatment ends, but the effect only lasted as long as the program.
A small study suggests that when diagnosed women have cognitive problems before starting treatment, the problems are likely due to post-traumatic stress caused by diagnosis.
A small study has found that cognitive behavioral stress management after breast cancer surgery offers long-term benefits to women.
To help doctors and patients understand which complementary therapies are safe and effective for people diagnosed with breast cancer, the Society for Integrative Oncology has published guidelines.
The American Society of Clinical Oncology has developed new guidelines on three problems that cancer survivors often deal with: fatigue, neuropathy, and anxiety and depression.
Research suggests that women taking the antidepressant Paxil at the same time as the hormonal therapy medicine tamoxifen are more likely to die from breast cancer than women taking tamoxifen who never took Paxil.
A study by Breastcancer.org Chief Medical Officer Marisa Weiss found that many teen girls worry about breast cancer and think their risk of breast cancer is higher than it really is.